newsfilter
← Latest News
ACCESS Newswire·

Aptevo Therapeutics Announces Exercise of Existing Warrants and PIPE for $4.5 Million Gross Proceeds

SEATTLE, WA / ACCESS Newswire / August 12, 2026 / Aptevo Therapeutics Inc. , a clinical-stage biotechnology company developing novel multispecific immuno-oncology